Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation of TGF-β/ALK5/SMAD signaling alleviates behavioral and neurochemical deficits in tramadol withdrawal.

Toxicology and applied pharmacology·2026
Same author

Transfusion Modalities in Thalassemia Patients: Prophylactic Antigen Matched Versus Usual Matched approach- Experience from Tertiary Care Hospital!

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Modulation of the AMPK/TFEB Axis by Ezetimibe Attenuates Neuroinflammatory, Oxidative Stress, and Neurotransmitter Dysregulation in Naloxone-precipitated Tramadol Withdrawal in Mice.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
Same author

Enhancing tensile strength of 3D-printed wood-PLA composites via a particle swarm optimization framework.

PloS one·2026
Same author

Sirolimus Therapy in Generalized Lymphatic Anomaly With Tuberculosis: A Case Report.

Pediatric pulmonology·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Image-guided pediatric airway endoscopy: A review.

Paediatric respiratory reviews·2026
Same journal

Bronchoscopic and interventional management of tracheobronchomalacia in children with bronchopulmonary dysplasia: a review of evidence.

Paediatric respiratory reviews·2026
Same journal

Hand in glove: New imaging techniques and airway endoscopy.

Paediatric respiratory reviews·2026
Same journal

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan.

Paediatric respiratory reviews·2026
Same journal

How to monitor response to biologics in children with severe asthma.

Paediatric respiratory reviews·2026
Same journal

Moving the goalposts from symptom control to preventing airway remodeling in preschool asthma.

Paediatric respiratory reviews·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumonia - management in the developing world.

Varinder Singh1, Satinder Aneja

  • 1Department of Paediatrics, Lady Hardinge Medical College and assoc Kalawati Saran Children's Hospital, Bangla Sahib Marg, N Delhi 110001, India. 4vsingh@gmail.com

Paediatric Respiratory Reviews
|December 22, 2010
PubMed
Summary
This summary is machine-generated.

Childhood pneumonia causes millions of deaths annually. Standardized protocols improve early detection and treatment, but facility-level care and accurate diagnosis of similar respiratory illnesses are crucial for reducing child mortality.

Related Experiment Videos

Last Updated: Jun 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

  • Pediatrics
  • Public Health
  • Infectious Diseases

Background:

  • Childhood pneumonias are a leading cause of mortality in children under five, contributing to over 2 million deaths annually.
  • Standardized case management protocols by the World Health Organization aid early detection and risk identification at the community level.
  • Most pneumonia-related deaths occur in healthcare facilities, highlighting the need for standardized facility-level treatment.

Purpose of the Study:

  • To emphasize the importance of standardizing treatment at the facility level for childhood pneumonia.
  • To address the challenge of differentiating pneumonia from other respiratory illnesses that mimic it.
  • To refine diagnostic and treatment strategies for high-risk groups, including malnourished and HIV-co-infected children.

Main Methods:

  • Adoption of standardized World Health Organization case management protocols.
  • Implementation of facility-level treatment standards including pulse oximetry and antibiotic use.
  • Focus on early detection and risk stratification in community settings.
  • Addressing challenges in differentiating pneumonia from other respiratory illnesses.

Main Results:

  • Standardized protocols facilitate early detection and risk identification in resource-constrained settings.
  • Facility-level standardization is critical for reducing mortality, requiring pulse oximetry and judicious antibiotic use.
  • Accurate differentiation of pneumonia from other respiratory illnesses is essential to avoid undertreatment or overtreatment.
  • Special considerations are needed for severely malnourished and HIV-co-infected children.

Conclusions:

  • Standardized community and facility-level management is vital for combating childhood pneumonia.
  • Accurate diagnosis and appropriate treatment, especially for complex cases, are key to reducing mortality.
  • Further refinement of strategies is necessary for vulnerable populations like malnourished and HIV-co-infected children.